Volume 38, Issue 5, Pages (May 2013)

Slides:



Advertisements
Similar presentations
Volume 40, Issue 4, Pages (April 2014)
Advertisements

Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Constitutively Active β-Catenin Confers Multilineage Differentiation Potential on Lymphoid and Myeloid Progenitors  Yoshihiro Baba, Karla P. Garrett,
Stromal-Derived Factor-1α and Interleukin-7 Treatment Improves Homeostatic Proliferation of Naïve CD4+ T Cells after Allogeneic Stem Cell Transplantation 
Volume 22, Issue 6, Pages (June 2005)
Following the Development of a CD4 T Cell Response In Vivo
Novel function for interleukin-7 in dendritic cell development
Volume 38, Issue 2, Pages (February 2013)
Volume 31, Issue 3, Pages (September 2009)
Wei Hu, Ty Dale Troutman, Ramakrishna Edukulla, Chandrashekhar Pasare 
Volume 30, Issue 4, Pages (April 2009)
Volume 41, Issue 1, Pages (July 2014)
by Dior Kingston, Michael A
Lung Natural Helper Cells Are a Critical Source of Th2 Cell-Type Cytokines in Protease Allergen-Induced Airway Inflammation  Timotheus Y.F. Halim, Ramona H.
Volume 26, Issue 4, Pages (April 2007)
Volume 30, Issue 4, Pages (April 2009)
Volume 15, Issue 6, Pages (June 2014)
Volume 18, Issue 5, Pages (May 2003)
Volume 29, Issue 2, Pages (August 2008)
Volume 29, Issue 2, Pages (August 2008)
Volume 33, Issue 1, Pages (July 2010)
Volume 42, Issue 3, Pages (March 2015)
Volume 31, Issue 2, Pages (August 2009)
Volume 34, Issue 2, Pages (February 2011)
Volume 27, Issue 2, Pages (August 2007)
Volume 33, Issue 4, Pages (October 2010)
Volume 42, Issue 6, Pages (June 2015)
Volume 39, Issue 3, Pages (September 2013)
Volume 29, Issue 6, Pages (December 2008)
Volume 40, Issue 4, Pages (April 2014)
Dysregulated Hematopoietic Stem and Progenitor Cell Activity Promotes Interleukin-23- Driven Chronic Intestinal Inflammation  Thibault Griseri, Brent S.
Clonal Acquisition of Inhibitory Ly49 Receptors on Developing NK Cells Is Successively Restricted and Regulated by Stromal Class I MHC  Claude Roth, James.
Volume 43, Issue 2, Pages (August 2015)
Volume 39, Issue 4, Pages (October 2013)
Ravindra Majeti, Christopher Y. Park, Irving L. Weissman 
Volume 29, Issue 6, Pages (December 2008)
Volume 21, Issue 1, Pages (July 2004)
Volume 36, Issue 2, Pages (February 2012)
Volume 15, Issue 3, Pages (April 2016)
Volume 25, Issue 3, Pages (September 2006)
Volume 28, Issue 4, Pages (April 2008)
Volume 33, Issue 4, Pages (October 2010)
Identification of a T Lineage-Committed Progenitor in Adult Blood
Volume 22, Issue 2, Pages (February 2005)
Volume 37, Issue 3, Pages (September 2012)
Volume 5, Issue 5, Pages (November 2015)
Volume 33, Issue 3, Pages (September 2010)
Volume 38, Issue 3, Pages (March 2013)
Volume 15, Issue 4, Pages (October 2001)
Volume 22, Issue 4, Pages (April 2005)
Volume 32, Issue 5, Pages (May 2010)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 24, Issue 1, Pages (January 2006)
Volume 29, Issue 5, Pages (November 2008)
Volume 24, Issue 6, Pages (June 2006)
Myung H. Kim, Elizabeth J. Taparowsky, Chang H. Kim  Immunity 
Volume 8, Issue 1, Pages (January 2011)
Volume 3, Issue 6, Pages (December 2014)
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 26, Issue 4, Pages (April 2007)
Volume 15, Issue 11, Pages (June 2016)
Volume 30, Issue 4, Pages (April 2009)
Volume 38, Issue 2, Pages (February 2013)
Volume 36, Issue 5, Pages (May 2012)
Tomokatsu Ikawa, Hiroshi Kawamoto, Lilyan Y.T. Wright, Cornelis Murre 
Toll-Dependent Control Mechanisms of CD4 T Cell Activation
Volume 20, Issue 6, Pages (June 2004)
Volume 38, Issue 3, Pages (March 2013)
Development and Function of Dendritic Cell Subsets
Volume 45, Issue 5, Pages (November 2016)
Presentation transcript:

Volume 38, Issue 5, Pages 943-957 (May 2013) A Clonogenic Progenitor with Prominent Plasmacytoid Dendritic Cell Developmental Potential  Nobuyuki Onai, Kazutaka Kurabayashi, Mayuka Hosoi-Amaike, Noriko Toyama-Sorimachi, Kouji Matsushima, Kayo Inaba, Toshiaki Ohteki  Immunity  Volume 38, Issue 5, Pages 943-957 (May 2013) DOI: 10.1016/j.immuni.2013.04.006 Copyright © 2013 Elsevier Inc. Terms and Conditions

Immunity 2013 38, 943-957DOI: (10.1016/j.immuni.2013.04.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 Identification of M-CSFR− DC Progenitors (A) Flow cytometric sorting of BM Lin− cells (left), those expressing Lin−c-Kitint/loFlt3+ (middle), and, of them, those expressing M-CSFR and IL-7Rα (right). Boxed areas: R1, Lin−c-Kitint/loFlt3+M-CSFR−IL-7Rα−; R2, CDPs (Lin−c-Kitint/loFlt3+M-CSFR+). (B–E) Ex vivo DC differentiation from sorted Lin−c-Kitint/loFlt3+M-CSFR−IL-7Rα− cells and CDPs. (B) Cells (2 × 104) were cultured in the presence of human Flt3L-Ig (100 ng/ml) and absolute numbers of pDC (CD45RA+CD11cint) and cDC (CD24hi cDCs and CD24lo cDCs) subpopulations on day 4, 8, and 12 of culture. (C) Flow cytometric profiles of the DC subsets. (D) PDCA-1 or Siglec-H expression (shaded) and corresponding isotype controls (open) on pDCs. (E) IFN-α production (1 μM CpG for 24 hr) on day 8 of culture. (F) On day 8 of culture, pDCs derived from Lin−c-Kitint/loFlt3+M-CSFR−IL-7Rα− cells and CDPs were stimulated with CpG for 24 hr, and IFN-α activity in the culture supernatants was evaluated by ELISA. ND, not detected. Means ± SEM are shown. n = 8 from five (A–D) or three (E, F) independent experiments. (G) Division-coupled differentiation into pDCs from Lin−c-Kitint/loFlt3+M-CSFR−IL-7Rα− cells (left) and CDPs (right). DC progenitors were labeled with CFSE and cultured in the presence of hFlt3L-Ig (100 ng/ml) for 2 days and 7 days. (H) May-Grünwald-Giemsa staining of sorted pDCs derived from Lin−c-Kitint/loFlt3+M-CSFR−IL-7Rα− cells (left) and CDPs (right). Original magnification, ×400. Data are representative of three independent experiments. See also Figure S1. Immunity 2013 38, 943-957DOI: (10.1016/j.immuni.2013.04.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 Limiting Dilution Analysis of M-CSFR− DC Progenitors (A and B) Limiting dilution analysis of M-CSFR− DC progenitors (A) and CDPs (B). Cells were cultured for 12 days with Ac6 stromal cells and hFlt3L-Ig (100 ng/ml); each well was analyzed for CD11c+ cells. Horizontal axis, number of plated cells. Dotted line, 37% negative “readout” showing the predicted frequency of CD11c+ progenitor cells in parentheses. Statistics details are described in Experimental Procedures. (C) Clonal analysis of M-CSFR− DC progenitors. Single progenitors gave rise to pDCs (left), cDCs (middle), or both (right). (D) Subsets of cDCs defined as in Figure 1C. (E) Single bipotential progenitors gave rise to both pDCs and cDCs. Some clones gave rise to comparable numbers of pDCs and cDCs (left), some clones gave rise to a large number of pDCs and some cDCs (middle), and other clones gave rise to some pDCs and many cDCs (right). Data are representative of three independent experiments. (F and G) Venn diagrams of the progenies of single M-CSFR− DC progenitors (F) or CDPs (G) sorted and plated at a density of 1 cell per well in 96-well plates (for a total of 182 wells) on irradiated Ac6 stromal cells in human Flt3L-Ig-supplemented media. Values represent the number of wells on day 12 with cells of the indicated type. Data are combined from three independent experiments. See also Figure S2. Immunity 2013 38, 943-957DOI: (10.1016/j.immuni.2013.04.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3 Characterization of M-CSFR− DC Progenitors (A and B) Histograms showing surface markers of M-CSFR− DC progenitors (A) and CDPs (B). Shaded areas, indicated molecules; open areas, corresponding isotype controls. (C) RNAs for DC lineage-associated genes were analyzed by qPCR in HSCs, MDPs, CDPs, M-CSFR− DC progenitors, pDCs, and cDCs. Data are representative of three independent experiments. See also Table S1. Immunity 2013 38, 943-957DOI: (10.1016/j.immuni.2013.04.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 4 In Vivo Differentiation Potential of M-CSFR− DC Progenitors (A and B) Flow cytometric profile of the spleen (A) and BM (B) 10 days after i.v. transplantation of 5 × 104 double-sorted M-CSFR− DC progenitors from B6 mice (CD45.2+) into irradiated B6.SJL mice (CD45.1+). Progenies were stained for CD11c, CD45RA, PDCA-1, Siglec-H, CD3ε, CD19, NK1.1, and TER119. (C and D) Absolute cell numbers of DC subsets in splenic progenies from M-CSFR− DC progenitors at the indicated time points (C) and from M-CSFR− DC progenitors or CDPs at day 10 (D). (E) Splenic pDC and cDC progenies were sorted, and the expression levels of Tlr7 and Tlr9 were analyzed by qPCR. Data are representative of two independent experiments. (F) Ten days after transplantation, M-CSFR− DC progenitor (pro.)-derived pDCs were sorted from the spleen and stimulated with 1 μM CpG for 24 hr, and the IFN-α concentrations in the culture supernatants were determined by ELISA. (G) Sorted M-CSFR− DC progenitor, CDPs, and MDPs were transplanted into lethally irradiated B6.SJL mice with rescue bone marrow. Ten days after transplantation, CpG + DOTAP was intravenously injected, and 24 hr later the serum IFN-α concentration was determined by ELISA. Data are representative of three independent experiments. ND, not detected. Error bars in (C), (D), (F), and (G) show the mean ± SEM. *p < 0.01. See also Figure S3. Immunity 2013 38, 943-957DOI: (10.1016/j.immuni.2013.04.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 5 M-CSFR− DC Progenitors as a Source of pDC Subsets (A) Flow cytometric analysis of CDPs, M-CSFR− DC progenitor, and classical lymphoid progenitors (Lin−c-Kitint/loFlt3+M-CSFR−IL-7Rα+) for Rag1 expression. (B–G) Flow cytometric profile (B–E, G) and absolute numbers (F) of spleen progeny 10 days after i.v. transplantation of 5 × 104 sorted M-CSFR− DC progenitors (B, C) and CDPs (D, E) from Rag1gfp/+ mice (CD45.2+) into irradiated B6.SJL mice (CD45.1+). The resulting pDCs were further analyzed for GFP (B, D) and CCR9 (C, E) amounts. The resulting cDCs were also analyzed for GFP amounts (G). Shaded histograms show CCR9 expression on Rag1− (left) and Rag1+ (right) pDCs; open histograms represent results from corresponding isotype controls. Cell numbers are graphed in (F). Data are representative of three independent experiments. Error bars in (F) show the mean ± SEM. *p < 0.01. See also Figure S4. Immunity 2013 38, 943-957DOI: (10.1016/j.immuni.2013.04.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 6 Relationship between the M-CSFR− DC Progenitors and CDPs Sorted M-CSFR− DC progenitors and CDPs (2 × 104) were cultured in the presence of hFlt3L-Ig (FL) (100 ng/ml), hFlt3L-Ig + M-CSF (20 ng/ml), hFlt3L-Ig + human TPO (20 ng/ml), or hFlt3L-Ig + M-CSF (20 ng/ml) + hTPO (20 ng/ml). (A) Flow cytometric profiles of the DC subsets. (B) Absolute numbers of the pDC and cDC subpopulations (CD24hi cDCs and CD24lo cDCs) on day 8 of culture. (C) Expression of Mpl on DC progenitors cultured with human Flt3L-Ig for 2 days. (D) Relative E2-2 mRNA expression in cytokine-stimulated DC progenitors at the indicated time points during culture. (E) DC progenitors were labeled with CFSE and cultured as indicated for 2 days. Data are representative of three independent experiments. Error bars in (B) and (D) show the mean ± SEM. *p < 0.01. See also Figure S5. Immunity 2013 38, 943-957DOI: (10.1016/j.immuni.2013.04.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 7 LMPPs Give Rise to M-CSFR− DC Progenitors, CDPs, and MDPs In Vivo Sorted and CFSE-labeled LMPPs (1 × 105 cells) were transplanted directly into the BM (intra-BMT) of nonirradiated B6.SJL mice. (A) Representative flow cytometric profiles of BM progenies 3 days after intra-BMT are shown. (B) Representative flow cytometric profiles of the progenies of sorted CFSE+LMPP-derived c-Kitint/loFlt3+M-CSFR− cells, c-Kitint/loFlt3+M-CSFR+ cells, and c-Kit+Flt3+M-CSFR+ cells and were cultured in irradiated stromal cells Ac6 with Flt3-ligand and TPO for 8 days. (C) Absolute numbers of pDC and cDC derived from different progenitors are shown. Error bars show the means ± SEM (n = 4 from two independent experiments). *p < 0.01. See also Figure S6. Immunity 2013 38, 943-957DOI: (10.1016/j.immuni.2013.04.006) Copyright © 2013 Elsevier Inc. Terms and Conditions